Pharmaceutical 3865 articles

Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.

Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.

Congressman Burgess defends controversial power morcellators


Texas Congressman Michael Burgess, a former gynecologist, is defending the use of controversial power morcellators for hysterectomies and uterine fibroid removals despite the risk of spreading cancer and worsening a woman’s odds of survival. Power morcellators are surgical tools fitted with a long tube-like blade that shreds entire uteruses or uterine growths inside the uterine cavity and removes them through a small incision in the abdomen. The procedures have been favored by many doctors over open surgeries because they are less invasive, leave less scar tissue, and offer shorter recovery. In recent years, the safety of the devices has come under ... Read More

Testosterone ineffective as treatment for ejaculatory dysfunction

Low T

Testosterone replacement therapy doesn’t benefit men with ejaculatory dysfunction, according to a study published in the July 9 issue of The Journal of Clinical Endocrinology & Metabolism. Testosterone treatments are used to increase the hormone levels in men with hypogonadism, a condition in which men do not produce enough testosterone due to injury or disease. The condition can cause symptoms such as low sex drive, muscle loss and fatigue. Ejaculatory dysfunction includes conditions such as delayed ejaculation, premature ejaculation and anejaculation. There is limited data to indicate whether testosterone deficiency may be a contributor to ejaculatory dysfunction in men. But ... Read More

Researchers explain reason for melanoma risk with Viagra


A new study published in the Journal of the American Medical Association warns that men who use the erectile dysfunction drug Viagra are twice as likely to develop the deadly skin cancer melanoma than men who did not use the drug. The study involved 25,000 male health professionals who were followed for 10 years. Researchers noted which men developed melanoma or other skin cancers, and whether they took Viagra. They found men who used or had ever used Viagra were at an increased risk of melanoma, but not other cancers such as basal cell carcinoma or squamous cell carcinoma. The ... Read More

Risperdal linked to prolonged erections, gynecomastia


The antipsychotic drug Risperdal has been associated with prolonged erections. The unwanted, persistent erection of the penis not caused by sexual stimulation or arousal is generally painful, and requires immediate medical attention. The side effect is so rare that doctors are not required to discuss it with patients who are prescribed the drug. But the Physicians’ Desk Reference lists reports of prolonged erections in patients treated with the meds. Risperdal, known generically as risperidone, is an antipsychotic drug used to treat adults and children with schizophrenia, bipolar disorder, and irritability with autism. It is sometimes used off-label to treat ADD, ... Read More

Kim Kardashian promotes controversial morning sickness drug

Kim Kardashian Diclegis - Instagram image

Kim Kardashian is profiting from her pregnancy by pushing a controversial morning sickness drug. Kardashian posted on Instagram a photo of herself with a bottle of Diclegis and a rather scripted message saying that her doctor prescribed the drug. “I’m so excited and happy with my results that I’m partnering with Duchesnay USA to raise awareness about treating morning sickness,” she writes. Diclegis is a combination of vitamin B6 and the antihistamine doxylamine. It is a delayed-release pill that is designed to be taken every day before symptoms occur. Nausea and vomiting associated with pregnancy generally occur in the morning, ... Read More

More patients being treated for atrial fibrillation


More patients than ever are being treated with blood thinners for the common irregular heart rhythm condition atrial fibrillation, thanks in part to direct-to-consumer advertising from the newest anticoagulants on the market. According to a study conducted by researchers with the University of Michigan Frankel Cardiovascular Center, doctors prescribed more than 2.83 million blood thinners in the last quarter of 2014, up about 800,000 from the start of 2009. Blood thinners are used to prevent strokes in patients with atrial fibrillation. They are also used to prevent or treat blood clots in the legs and lungs, a condition known as ... Read More

Johnson & Johnson announces declining sales in all three divisions


Consumer health care giant Johnson & Johnson recently reported concerning second-quarter earnings with overall sales down 8.8 percent from the same quarter last year. Some of the blame falls on the company’s medical devices division, which saw declining sales for the fourth straight quarter with not much hope for growth on the horizon, according to analysts. All three of Johnson & Johnson’s divisions – consumer products, medical devices, and pharmaceuticals – have experienced quarterly declines for the past few years. The majority of the declines were attributed to foreign exchange fluctuations, but sales in each division were weak. Declines in the company’s ... Read More

Study investigates testosterone side effects

Low T

Last year, the Food and Drug Administration (FDA) ordered manufacturers of testosterone replacement products to add blood clot warnings to the safety labels of the hormones. A new study suggests testosterone supplements may not increase the risk of blood clots, but the risk for heart attacks and strokes in patients who use the therapy remains. The most common forms of blood clots in the veins, also known as venous thromboembolism (VTE), are deep vein thrombosis (blood clot in the leg) and pulmonary embolism (blood clot in the lungs). It is the third most common cardiovascular problem after heart attacks and ... Read More

Europe approves first-in-class cholesterol-lowering drug


European drug regulators have approved Amgen’s highly anticipated, first-of-a-class cholesterol-lowering drug Repatha, for patients with dangerously high cholesterol levels, including those with inherited conditions, and people who cannot tolerate statin side effects. Repatha is an injectable drug from an experimental class of drugs known as PCSK9 inhibitors. Other PCSK9 drugs are currently in development or awaiting review by drug regulators. Drugs in this class have shown in clinical trials to be superior at dramatically lowering LDL – or bad – cholesterol. Like statins, the drugs are used to prevent heart attacks and strokes in patients with high cholesterol, a risk ... Read More

Judge refuses to dismiss Prozac birth defects lawsuit

preemie baby

A lawsuit filed by a woman who claims taking Eli Lilly & Co.’s antidepressant Prozac during pregnancy caused her child to be born with a heart defect will move forward after an Alabama federal court refused the drug company’s motion to dismiss the case. U.S. District Judge Keith Watkins found that the plaintiff, Dana Fields, had a genuine dispute against Eli Lilly, and that she could show factual causation that her doctor would not have prescribed the drug to her had he known the risks, even though the doctor is now deceased. Fields claims that in 1996 she took Prozac ... Read More